Track recorded fund announcements, transactions, leadership appointments and strategic developments from DataBane's published research.
ChrysCapital announced publication of its FY2026 ESG report, Investing in Resilience, Creating Sustainable Value. The announcement highlights climate-risk assessments, a new Human Rights Policy and formal ESG assessment, due-diligence, exit and incident-reporting frameworks.
ChrysCapital announced its investment in Linux Laboratories, an Indian domestic formulations business with a focus on central nervous system therapies. The firm said it would support the company’s next phase of growth. Transaction adviser Avendus separately reported a combined USD 70 million investment from ChrysCapital and Tata Capital Healthcare Fund. Individual investor contributions were not disclosed.
ChrysCapital announced its participation in SuperReturn Asia 2026, represented by Senior Partner Ashley Menezes and Managing Director and CFO Puneet Chadha.
ChrysCapital announced that Rajiv Batra, Managing Director at ChrysCapital Advisors, had been selected for The Economic Times 40 Under Forty 2026 list.
Kedaara-backed Universal NutriScience entered a competitive sale process. Warburg Pincus was reported as frontrunner with ChrysCapital also shortlisted. The reported transaction value is INR 2,700–2,800cr. Kedaara is expected to exit if the transaction closes.
ChrysCapital announced Rachit Mathur’s appointment as Managing Director and Head of Enhancin, its portfolio value-creation platform. The firm also acknowledged Parampreet Singh Bhasin’s role in building Enhancin and said he had decided to pursue an entrepreneurial venture in packaged foods.
